Chronic Administration of Marinobufagenin in Mice Causes Hyperlocomotion and Decrease in Anxiety by Altering Monoamine Turnover Unaccompanied by Motor Deficits or Oxidative StressRogneda B. Kazanskaya, Alexander V. Lopachev, Vassiliy Tsytsarev et al.|International Journal of Molecular Sciences|2026Cited by 0